Moreover, it was reported that a higher circulating FGF23 is associated with increased cardiovascular morbidity and a higher risk of mortality in type 2 diabetes (T2D) patients with a normal or mildly impaired kidney function [20], despite the precise mechanisms remaining unclear. This evidence concerns the gene FGF23 and type 2 diabetes mellitus.